The Optimal Timing and Duration of Daily G‐CSF for the Primary Prevention of Febrile Neutropenia in Breast Cancer Patients Undergoing Adjuvant TAC Chemotherapy
Initiating filgrastim on Day 2 of TAC chemotherapy significantly enhances its effectiveness in preventing FN compared to starting on Day 5. These findings support early intervention and sustained treatment to optimize toxicity management in adjuvant TAC chemotherapy.
Authors
- Jong Eun Lee (ORCID: https://orcid.org/0000-0002-8754-6801)
- Sun Wook Han (ORCID: https://orcid.org/0000-0002-0671-1212)
- Cheol Wan Lim (ORCID: https://orcid.org/0000-0001-9490-4964)
- Jihyoun Lee
- Sung Mo Hur (ORCID: https://orcid.org/0000-0001-8547-5635)
- Hae Il Jung (ORCID: https://orcid.org/0000-0003-2502-0086)
- Sung Yong Kim (ORCID: https://orcid.org/0000-0002-2070-0915)
- Zisun Kim (ORCID: https://orcid.org/0000-0002-1413-2800)
Institutions
- Soonchunhyang University (KR)
- Soonchunhyang University Hospital Seoul (KR)
- Bucheon University (KR)
Publication Details
- Journal
- Asia-Pacific Journal of Clinical Oncology
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1111/ajco.14165
- Citations
- 1
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.05